HBCM
CCEL icon

Heron Bay Capital Management’s Cryo-Cell International CCEL Stock Holding History

Heron Bay Capital Management’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,913
Closed -$197K – 118
2025
Q1 		$197K Sell
30,913
-853
-3% -$6.19K 0.04% 87
2024
Q4 		$235K Buy
+31,766
New +$240K 0.05% 80

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Heron Bay Capital Management's CCEL Position: Q2 2025 in Review

Heron Bay Capital Management sold out of Cryo-Cell International (CCEL) in Q2 2025, closing a stake of 30,913 shares — an estimated $197K sold.

Heron Bay Capital Management first reported a position in CCEL in Q4 2024 and held it in 2 quarters. The position peaked at $235K in Q4 2024. 20 funds tracked by Wall St. Rank hold CCEL as of Q2 2025.

  • Heron Bay Capital Management reported no remaining Cryo-Cell International position as of Q2 2025 after selling out during the quarter.
  • Heron Bay Capital Management sold 30,913 Cryo-Cell International shares in Q2 2025, an estimated $197K.
  • Heron Bay Capital Management first reported a position in Cryo-Cell International in Q4 2024 and held it in 2 quarters.
  • Heron Bay Capital Management's Cryo-Cell International position peaked at $235K in Q4 2024.
  • 20 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2025.

Based on Heron Bay Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.